CCAR2-regulated superenhancers are enriched with TCF4/LEF1-binding motifs, and their target genes are enriched in pathways associated with CRC progression and are highly expressed in CRC tissues compared with normal colon tissues. The gene discussed is CCAR2; the disease is colorectal carcinoma.